Title: Oksenberg D, et al. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease. Br J Haematol. 2016 Oct;175(1):141-53.
168165-88-6 | 4-(1,3-Dithian-2-yl)benzoic acid | AA00ABSA | MFCD06208216
193975-33-6 | Ethyl 4-chloro-8-iodoquinoline-3-carboxylate | AA00AC11 | MFCD09991531
16925-15-8 | DIMETHYLBIS(2,4-PENTANEDIONATE)TIN | AA00ACBY | MFCD08275536
154411-16-2 | N-(1-Cyano-4-oxo-4H-quinolizin-3-yl)benzamide | AA00ACQB | MFCD00793861
19564-13-7 | N-Methyl-2-(3-oxo-2-piperazinyl)acetamide | AA00ACVT | MFCD12026519
172476-18-5 | 5-[(7-Chloro-4-quinolinyl)amino]-2-hydroxybenzaldehyde | AA00AD3V | MFCD18816297
19503-22-1 | 1H-Benzotriazole-1-carboxamidine Hydrochloride | AA00AD9S | MFCD18379189
184972-11-0 | FCE 27473 | AA00ADFJ
153725-04-3 | 1,8-Bis diphenylphosphanyl naphthalene | AA00ADPF | MFCD04117326
193281-00-4 | N-[4-[2-(2-AMino-4,5,6,7-tetrahydro-4,6-dioxo-1H-pyrrolo[2,3-d]pyriMidin-5-yl)ethyl]benzoyl]-L-glutaMic Acid | AA00ADX5 | MFCD31563146